Ensysce Biosciences, Inc. ·
ENSC 8-K 2026-09-29
Ensysce Biosciences, Inc. (ENSC) 8-K dated 2026-09-29 — accession 0001493152-26-044802.
Ensysce Biosciences, Inc. (ENSC) is a biotechnology company listed on US.
Ensysce Biosciences, Inc. filed a 8-K on 2026-09-29. Accession 0001493152-26-044802.
This 8-K covers: Bylaws or fiscal year change (Item 5.03), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported ENSC revenue for 2025-12-31 was $5.1M. Net income was -$10.2M. Revenue was down 2.8% from 2024-12-31 to 2025-12-31. ENSC currently screens at market cap $5.2M.
Not investment advice. The ENSC SEC hub lists recent forms. The stock page is the research view.